4 min read
ASCO 2026: RAS Is No Longer Undruggable
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
Veristat and SFL, a Veristat company, will attend the CPhI Worldwide 2022
Veristat and SFL, a Veristat company, will attend the CPhI Worldwide 2022
on the 1-3 November 2022 in Frankfurt
If you would like to meet us at the CPhI Worldwide 2022 , feel free to contact us to arrange a meeting through the form.

Website: CPHI Frankfurt | Where Business Meets Science
4 min read
Jun 15, 2026 Veristat News
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
10 min read
Jun 12, 2026 Veristat Blog
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...